Barclays maintains Equal-Weight on Avista, raises target to $40

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Barclays analyst Michael Lonegan maintained an Equal-Weight rating on Avista and raised the price target to $40 from $39.

powered bylight_fuzz_icon
44885991

*this image is generated using AI for illustrative purposes only.

Barclays analyst Michael Lonegan maintained an Equal-Weight rating on Avista while raising the price target to $40 from $39. The adjustment reflects a revised outlook on the stock's valuation.

Rating and Target Details

The research note confirms the Equal-Weight stance, indicating a neutral performance expectation relative to the broader market. The new price target of $40 represents a modest increase from the previous $39 objective.

Metric Value
Rating Equal-Weight
Previous Price Target $39
New Price Target $40
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove the revision in Avista's valuation outlook?

How might Avista's upcoming earnings report influence the new price target?

What are the potential risks that could prevent Avista from reaching the $40 target?

like18
dislike

Barclays lowers Avista price target to $39, maintains Equal-Weight

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Barclays analyst Michael Lonegan maintained an Equal-Weight rating on Avista and lowered the price target to $39 from $42, reflecting a revised valuation outlook for the NYSE-listed utility.

powered bylight_fuzz_icon
43080794

*this image is generated using AI for illustrative purposes only.

Barclays analyst Michael Lonegan has maintained an Equal-Weight rating on Avista while lowering the price target to $39 from $42. The revised target indicates a recalibrated valuation outlook for the NYSE-listed utility company.

The rating action follows a review of Avista's financial position and market performance. The Equal-Weight designation suggests the stock is expected to perform in line with the broader sector averages.

Metric Previous Revised
Price Target $42 $39
Rating Equal-Weight Equal-Weight

Avista trades on the NYSE under the ticker symbol AVA. The price target reduction signals a more conservative stance on the stock's near-term upside potential.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific financial factors led Barclays to adopt a more conservative stance on Avista's valuation?

How might Avista's upcoming earnings report influence the current Equal-Weight rating?

What are the potential risks or opportunities in the broader utility sector that could impact Avista's performance?

like15
dislike

More News on Avista